Revolution Medicines, Inc.
Status: Publicly traded
Direct answer
Revolution Medicines, Inc. is publicly traded on NASDAQ under the ticker RVMD.
Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The...
Can you invest in Revolution Medicines, Inc.?
Yes. Revolution Medicines, Inc. is publicly traded on NASDAQ under the ticker RVMD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Revolution Medicines, Inc.
Detailed equity research is provided by MarketSnap.